Predictive Analytics Model Validation & Implementation Checklist

Purpose

This checklist helps analytics, clinical, operations, and privacy teams reliably validate and safely operationalize predictive models that identify patients for outreach, escalated care, or early intervention. Use it as a reproducible validation workflow and a communication artifact for governance decisions.

How to use this checklist

Walk through each section and record evidence, numeric results, attachments (plots, code snippets, evaluation tables), reviewer name, and date. Treat any "No" or missing evidence as a gating item requiring remediation or a pilot with limited scope before full deployment.

Basic metadata

• Model name & version
• Primary intended use (population, intervention, decision point)
• Owner / sponsoring clinical lead
• Development dataset dates and sources
• Deployment target (EHR, care-management platform, manual list)

Data & sampling checks

• Data-split strategy documented: temporal split (preferred for deployment), patient-level split (no patient leakage), or nested cross-validation. Note seed values and rationale.
• Training / validation / test sets described: sizes, time windows, inclusion/exclusion criteria.
• Feature provenance & definitions: canonical feature list, transformations, derived features, lookback windows, and caching logic.
• Missing data strategy: imputation method or missingness as feature. Demonstrate robustness to plausible missingness patterns.
• Data quality checks performed: duplicates, implausible values, label noise, and how label-generating logic may have changed over time.
• Covariate drift assessed: baseline vs. most recent data distributions and documented expected vs. unexpected shifts.

Performance & evaluation

• Primary metrics chosen & justified: e.g., AUC for ranking, sensitivity/recall for case-finding, PPV for resource-constrained outreach, calibration metrics for risk thresholds. Explain why the metric matches the clinical decision.
• Results on held-out test set: numeric values with confidence intervals or bootstrapped SEs. Include plots: ROC, precision-recall, calibration curve.
• Calibration checks: calibration-in-the-large, calibration slope, and visual calibration plots. If probabilities are used for decisions, report decision-relevant calibration (e.g., observed outcome rate at a threshold).
• Threshold selection rationale: show tradeoffs (sensitivity vs. PPV), capacity-driven threshold choices, and expected volume of alerts/referrals.
• Prospective / temporal validation: performance on the most recent time window that mirrors deployment timeframe.
• External validation: results on an independent dataset or an external partner site where available.

Fairness & subgroup analysis

• Subgroups defined: by age group, sex, race/ethnicity where ethically and legally appropriate, socioeconomic proxies, language, comorbidity categories.
• Performance by subgroup: report primary metrics for each subgroup and compare against overall results. Flag > pre-defined relative drops (example: >10% drop in sensitivity) for review.
• Calibration by subgroup: check whether predicted probabilities match observed incidence across groups.
• Bias mitigation steps: reweighting, recalibration, threshold adjustments, or changing features. Document chosen approach and impact on overall and subgroup metrics.

Clinical utility & workflow fit

• Intended intervention described: what action follows a positive prediction, who acts, and expected clinical benefit.
• Decision curve / net benefit analysis performed: where practical, demonstrate net clinical benefit across thresholds.
• Capacity & downstream workload estimated: expected daily/weekly outreach volume and staff time required. Ensure thresholds match available capacity.
• User experience considerations: how predictions are presented (scores, categories, risk bands), explainability elements, and clinician-facing guidance.

Safety, privacy & legal review

• PHI & data-handling reviewed: permissible data use, storage location, retention, and minimum necessary principles.
• Security assessment: access controls, encryption, and logging for model outputs and inference calls.
• Regulatory / compliance check: any required approvals (IRB, privacy officer, legal) completed or in progress.

Deployment gating & governance

• Gates required before deployment: clinical sponsor sign-off, privacy/security sign-off, prospective pilot plan, monitoring plan in place, and training for users.
• Assigned owners: model owner, monitoring owner, clinical escalation contact, and an operational lead for retraining/maintenance.
• Escalation & rollback criteria: clear triggers for pausing or rolling back the model (e.g., sudden drop in AUC, sustained drop in PPV, safety incident, or unintended disparity).

Post-deployment monitoring & maintenance

• Monitoring plan documented: frequency, responsible team, dashboards, and alerting thresholds.
• Sample monitoring KPIs (examples):
  • Data drift score (statistical distance) weekly — alert if drift > pre-defined threshold.
  • AUC / ROC trend monthly — unexpected drop > X% triggers review.
  • Calibration shift (difference between predicted and observed risk in recent window) monthly.
  • Alert rate (number of predicted-high patients per week) vs. expected volume; unexpected surge triggers check.
  • PPV & sensitivity in a rolling 90-day window where labels are available.
  • False positive impact metric (e.g., unnecessary outreach rate).
  • Utilization: percent of clinician-targeted alerts acknowledged or acted upon.
• Retraining / recalibration triggers defined: data drift beyond threshold, sustained metric decline, scheduled periodic retrain cadence (e.g., quarterly) or after a major upstream change.
• Logging & auditability: store scores, inputs (or hashes), inference timestamps, and decision outcomes for later review and model auditing.

Pilot & rollout guidance

• Start with a limited prospective pilot in a constrained clinical area or with simulated alerts to measure operational impact before full integration.
• Collect both quantitative outcomes (KPI trends) and qualitative feedback from users.
• Define acceptance criteria for moving from pilot to full deployment (e.g., target PPV, clinician acceptance rate, no critical safety issues).

Example validation report structure (deliverable)

1. Executive summary: purpose, primary results, recommendation.
2. Model & data metadata: versions, datasets, inclusion rules.
3. Evaluation results: metrics, confidence intervals, plots (ROC, PR, calibration).
4. Subgroup & fairness analysis: tables and commentary.
5. Clinical utility assessment: threshold choice, expected volume, interventions.
6. Safety, privacy & legal reviews status.
7. Deployment gating checklist and sign-offs.
8. Monitoring plan and KPI dashboard links.
9. Pilot plan & acceptance criteria.

Quick-pass checklist (yes/no items to record)

• Model purpose & owner documented: Yes / No
• Data-split appropriate (no leakage): Yes / No
• Primary performance metrics meet pre-specified targets: Yes / No
• Calibration acceptable for decision use: Yes / No
• Subgroup fairness checks performed & acceptable: Yes / No
• Clinical sponsor approves the use-case & intervention: Yes / No
• Monitoring plan with KPIs & thresholds in place: Yes / No
• Deployment gates & rollback criteria defined: Yes / No
• Privacy & security review complete: Yes / No
• Pilot plan approved and scheduled: Yes / No

Sign-off

Model validation completed by: __________________   Date: __________

Clinical sponsor sign-off: __________________   Date: __________

Privacy / Security sign-off: __________________   Date: __________